Meta-analyses and systematic reviews on myocardial revascularization: comparing survival, myocardial infarction, repeated revascularization and angina symptom reduction rates
Abstract
The review summarizes data of meta-analyses and systematic reviews on comparative myocardial revascularization results. The review has been performed according to Cochrane Review Database method, without quantitative data pooling into one meta-analysis. Coronary artery bypass grafting (CABG) surgery is more effective than pharmaceutical treatment (PHT) in improving survival, but not in preventing myocardial infarction (MI) among some patients. CABG is more effective than endovascular myocardial revascularization in prevention of repeated revascularization, but not in improving quality of life (with diabetic patients as an exception). Coronary artery stenting is more effective than transluminal balloon angioplasty in reducing recurrent revascularization rates, but not in increasing life expectancy or preventing MI (similar results obtained for coated an non-coated stents). Clinical practice use of randomized trial and meta-analysis results is restricted by rapid development of medical technologies.
About the Author
I. V. Samorodskaya
A.N. Bakoulev Research Center for Cardiovascular Surgery. Moscow
Russian Federation
Russian Federation
References
1. Бокерия Л.А., Ступаков И.Н., Самородская И.В. Оценка эффективности методов реваскуляризации миокарда в рандомизированньж исследованиях (систематический обзор). Бюллетень НЦССХ Сердечно-сосудистые заболевания. Общие вопросы сердечно-сосудистой хирургии. Сентябрь-октябрь 2001; 2(5): 16-50.
2. Бокерия Л.А., Алекян Б.Г., Закарян Н.В., Стаферов А.В. Коронарные стенты с лекарственным покрытием для лечения больных ИБС (обзор). Груд серд-сосуд хир 2004; 2: 48-51.
3. Соломон А.Д., Герш Б.Д Лечение хронической стабильной стенокардии: анализ результатов рандомизированных исследований. Перевод. МЖМП 1999; 8: 27-33.
4. АСС/АНА 2004 Guideline Update for Coronary Artery Bypass Graft Surgery. JACC 2004; V44(5): 1146-54. Полный текст www.acc.org
5. Bakhai A., Hill R.A., Dundar Y., et al. Percutaneous transluminal coronary angioplasty with stents versus coronary artery bypass grafting. The Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD004588.pub3 DOI: 10.1002/14651858.CD004588.pub3
6. Blumenthal RS, Cohn G, Schulman SP. Medical Therapy Versus Coronary Angioplasty in Stable Coronary Artery Disease: A Critical Review of the Literature. JACC 2000; 367h(3): 668773.
7. Braunwald E., ed. Heart Disease: A Textbook of Cardiovascular Medicine. 5th ed. Philadelphia, Pa: WB Saunders Company 1998; Chapter 52.
8. Burzotta F., Trani C., Prati., et al. Comparison of outcomes of direct stenting (meta-analysis of 10 randomized trials. Am J Card 2003; 91: 790-6.
9. Cummings J.P., Ratko Т.А., Matuszewski K.A. Transmyocardial laser revascularization: a qualitative systematic review. Am J of Managed Care 1998; 4(Sp Iss): SP152-66.
10. Cundiff D.K. Coronary artery bypass grafting (CABG): reassessing efficacy safety and cost. Med Gen Med 2002; 4(2): 7-14.
11. Detre K.M., Holubkov R. Coronary revascularization on balance. Mayo Clin Proc 2002; 77(1): 72-82.
12. Dobesh P.P., Stacy Z.A., Ansara A.J., Enders J.M., Drug-Eluting Stents: A Mechanical and Pharmacologic Approach to Coronary Artery Disease. Pharmacotherapy 2004; 24(11): 1554-77.
13. Filart R.A., Ryan T.J. Comparison of coronary angioplasty bypass surgery for multivessel disease. Cor artery dis 1993; 4(12): 1039-47.
14. Gunnell D., Harvey I., Smith L. The invasive management of angina. J Epidemiol Commun Health 1995; 49: 335-43.
15. Hueb W.A., Soares P.R., Gersh B.J. The Medicine, angioplasty or surgery study (MASS II). JACC 2004; 43: 1743-51.
16. Kwok Y.S., Kim C., Heidenreich P.A. Medical therapy or coronary artery bypass graft surgery for chronic stable angina. Am J Med 2001; 111(2): 89-95.
17. Liao L., Sarria-Santamera A., Huntington A., et al. Meta-analisis of survival and angina relief after transmiocardial revascularization. JACC 2005; 45(Suppl A): 357A.
18. Mercado N., Boersna E. CABG vs Stenting for Multivessel Disease:a Meta-analysis of ARTS-1, SoS, ERACI-2, and MASS-2. Eur Society of Cardiology Congress 2003. (www.med-scape.com <http://scape.com>)
19. Mori M., Kurogane H., Hayashi T., et al. Comparison of result of intracoronary implantation of Palmaz-Schatz stent with convertional balloon angioplasty. Am J Cardiol 1996; 78: 985-9.
20. Peterson E.D., Lansky A.J., Anstrom K.J., et al. Evolving trends in interventional device use and outcomes: results from the National Cardiovascular Network Database. Am Heart J 2000; 139: 198-207.
21. Pocock S.J. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet 1995; 346(8984): 1184-9.
22. Pons J.M.V. Transmyocardial revascularization with laser. Scottish Health Purchasing Information Centre (SHPIC). IN96009. 1996.61.
23. Pretre R., Turina M.I. Analysis of trials of surgery vs angioplasty in myocardial revascularization. Semin Interv Cardiol 1999; 4(4): 235-43.
24. Scott N.A., Knight J.L., Bidstrup B.P., et al. Systematic review of beating heart surgery with the Octopus Tissue Stabilizer. Eur J Cardiothorac Surg 2002; 21(5): 804-17.
25. Serruys P.W., Kay I.P., Disco C., et al. Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis. JACC 1999; 34(4): 1067-74.
26. Sim I.С. A meta-analysis of randomized trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty. Am J Cardiol 1995; 76(14): 1025-9.
27. Stents for coronary artery disease. The Wessex Institute for Health Research and Development. The Cochrane Database of Systematic Reviews number DARE-989742.
28. Suwaidi J.A., Holmes D.R., Salam A.M., et al. Impact of Coronary Artery Stents on Mortality and Nonfatal Myocardial Infarction: Meta-analysis Comparing a Strategy of Routine Stenting With That of Balloon Angioplasty. Am Heart J 2004; 147(5): 815-22.
29. Transmyocardial laser revascularisation. Canberra:Medicare Services Advisory Committee. (MSAC). MSAC application 100. 1999. 22. <http://www.health.gov.au/haf/msachttp>
30. Van-Belle E., Bauters C., Hubert E. Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 1997; 96(5): 1374-7.
31. Vetrovec G.W., Drug-Eluting Stents: Current Outcomes and Potential Impact on Coronary Disease Management. J Invasive Cardiol 2002; 14(11): 708-12.
32. Villanueva E.V., Wasiak J., Petherick E.S. Percutaneous transluminal rotational atherectomy for coronary artery disease. The Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD003334 DOI: 10.1002/14651858.CD003334
33. Weintraub W.S. Economics and outcomes of coronary stenting: are stents right for everybody? J Invas Cardiol 2000; 12(4): 200-2.
34. Yusuf S. Effectof coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994; 344(8922): 563-70.
Review
For citations:
Samorodskaya I.V. Meta-analyses and systematic reviews on myocardial revascularization: comparing survival, myocardial infarction, repeated revascularization and angina symptom reduction rates. Cardiovascular Therapy and Prevention. 2006;5(8):90-100. (In Russ.)
Views:
729
Email this article 
